X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Wockhardt - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs WOCKHARDT LTD. - Comparison Results

WOCKHARDT LTD. 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE WOCKHARDT LTD. SUVEN LIFE/
WOCKHARDT LTD.
 
P/E (TTM) x 20.1 -18.2 - View Chart
P/BV x 3.7 3.0 124.6% View Chart
Dividend Yield % 1.0 1.1 91.2%  

Financials

 SUVEN LIFE   WOCKHARDT LTD.
EQUITY SHARE DATA
    SUVEN LIFE
Mar-16
WOCKHARDT LTD.
Mar-17
SUVEN LIFE/
WOCKHARDT LTD.
5-Yr Chart
Click to enlarge
High Rs3391,129 30.0%   
Low Rs144627 23.0%   
Sales per share (Unadj.) Rs39.2363.1 10.8%  
Earnings per share (Unadj.) Rs7.5-20.4 -36.5%  
Cash flow per share (Unadj.) Rs8.8-7.0 -125.8%  
Dividends per share (Unadj.) Rs2.0010.00 20.0%  
Dividend yield (eoy) %0.81.1 72.7%  
Book value per share (Unadj.) Rs49.0301.8 16.2%  
Shares outstanding (eoy) m127.28110.55 115.1%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x6.22.4 254.5%   
Avg P/E ratio x32.4-42.9 -75.4%  
P/CF ratio (eoy) x27.5-125.9 -21.9%  
Price / Book Value ratio x4.92.9 169.4%  
Dividend payout %26.8-48.9 -54.8%   
Avg Mkt Cap Rs m30,73297,063 31.7%   
No. of employees `0001.06.8 14.1%   
Total wages/salary Rs m4169,665 4.3%   
Avg. sales/employee Rs Th5,236.15,931.8 88.3%   
Avg. wages/employee Rs Th436.51,428.1 30.6%   
Avg. net profit/employee Rs Th995.5-334.0 -298.1%   
INCOME DATA
Net Sales Rs m4,99540,146 12.4%  
Other income Rs m1941,143 16.9%   
Total revenues Rs m5,18941,289 12.6%   
Gross profit Rs m1,233128 963.0%  
Depreciation Rs m1671,489 11.2%   
Interest Rs m542,253 2.4%   
Profit before tax Rs m1,205-2,472 -48.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m255-211 -120.8%   
Profit after tax Rs m950-2,260 -42.0%  
Gross profit margin %24.70.3 7,739.3%  
Effective tax rate %21.28.5 247.8%   
Net profit margin %19.0-5.6 -337.7%  
BALANCE SHEET DATA
Current assets Rs m4,98646,160 10.8%   
Current liabilities Rs m1,04219,258 5.4%   
Net working cap to sales %79.067.0 117.8%  
Current ratio x4.82.4 199.6%  
Inventory Days Days61101 60.5%  
Debtors Days Days3994 41.6%  
Net fixed assets Rs m3,12640,165 7.8%   
Share capital Rs m127553 23.0%   
"Free" reserves Rs m3,71732,814 11.3%   
Net worth Rs m6,23633,367 18.7%   
Long term debt Rs m43231,903 1.4%   
Total assets Rs m8,07989,687 9.0%  
Interest coverage x23.2-0.1 -23,913.8%   
Debt to equity ratio x0.11.0 7.3%  
Sales to assets ratio x0.60.4 138.1%   
Return on assets %12.40 -144,730.6%  
Return on equity %15.2-6.8 -224.8%  
Return on capital %18.9-0.3 -5,631.4%  
Exports to sales %87.50-   
Imports to sales %12.20-   
Exports (fob) Rs m4,371NA-   
Imports (cif) Rs m611NA-   
Fx inflow Rs m4,6669,121 51.2%   
Fx outflow Rs m9422,133 44.2%   
Net fx Rs m3,7246,988 53.3%   
CASH FLOW
From Operations Rs m922-2,695 -34.2%  
From Investments Rs m-619-6,863 9.0%  
From Financial Activity Rs m-69812,545 -5.6%  
Net Cashflow Rs m-3963,010 -13.1%  

Share Holding

Indian Promoters % 63.4 74.5 85.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 2.3 -  
FIIs % 0.0 7.7 -  
ADR/GDR % 0.0 0.1 -  
Free float % 36.5 15.4 237.0%  
Shareholders   37,287 67,757 55.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   ALEMBIC PHARMA  FRESENIUS KABI ONCO.  TTK HEALTHCARE  ASTRAZENECA PHARMA  DISHMAN PHARMA  

Compare SUVEN LIFE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Jan 19, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE 8-QTR ANALYSIS

COMPARE SUVEN LIFE WITH

MARKET STATS